Evidence map›Paper›PMID 31514745›Full record

Trial reportAIDS research and therapy2019

Repeat HIV testing of individuals with discrepant HIV self-test results in Central Uganda.

Rose Kisa, Joseph K B Matovu, Esther Buregyeya, William Musoke, Caroline J Vrana-Diaz, Jeffrey E Korte, Rhoda K Wanyenze

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS research and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Rose KisaDepartment of Disease Control and Environmental Health, School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda.
Joseph K B MatovuDepartment of Disease Control and Environmental Health, School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda. jmatovu@musph.ac.ug.ORCID 0000-0001-6480-2940
Esther BuregyeyaDepartment of Disease Control and Environmental Health, School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda.
William MusokeResearch Department, Mildmay Uganda, Kampala, Uganda.
Caroline J Vrana-DiazSchool of Public Health, Medical University of South Carolina, Charleston, SC, USA.
Jeffrey E KorteSchool of Public Health, Medical University of South Carolina, Charleston, SC, USA.
Rhoda K WanyenzeDepartment of Disease Control and Environmental Health, School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda.
Makerere University · UGMedical University of South Carolina · USBusitema University · UGMildmay Uganda · UG

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
FIC NIH HHS D43 TW010540
6 · The paper itself

Abstract

backgroundAccording to the user instructions from the manufacturer of OraQuick HIV self-test (HIVST) kits, individuals whose kits show one red band should be considered to be HIV-negative, no matter how weak the band is. However, recent reports show potential for a second false weak band after storage, thereby creating confusion in the interpretation of results. In this study, we re-tested individuals whose results were initially non-reactive but changed to weak reactive results to determine their true HIV status.

methodsThis study was nested within a large, cluster-randomized HIVST trial implemented among pregnant women attending antenatal care and their male partners in central Uganda between July 2016 and February 2017. Ninety-five initially HIV-negative respondents were enrolled into this study, including 52 whose kits developed a second weak band while in storage and 43 whose kits were interpreted as HIV-positive by interviewers at the next follow-up interview. Respondents were invited to return for repeat HIVST which was performed under the observation of a trained nurse counsellor. After HIVST, respondents underwent blood-based rapid HIV testing as per the national HIV testing algorithm (Determine (Abbot Laboratories), STAT-PAK (Chembio Diagnostic Systems Inc.) and Unigold (Trinity Biotech plc.) and dry blood spots were obtained for DNA/PCR testing. DNA/PCR was considered as the gold-standard HIV testing method.

resultsAfter repeat HIVST, 90 (94.7%) tested HIV-negative; 2 (2.1%) tested HIV-positive; and 3 (3.2%) had missing HIV test results. When respondents were subjected to blood-based rapid HIV testing, 97.9% (93/95) tested HIV-negative while 2.1% (2/95) tested HIV-positive. Finally, when the respondents were subjected to DNA/PCR, 99% (94/95) tested HIV-negative while 1.1% (1/95) tested HIV-positive.

conclusionsNearly all initially HIV-negative individuals whose HIVST kits developed a second weak band while in storage or were interpreted as HIV-positive by interviewers were found to be HIV-negative after confirmatory DNA/PCR HIV testing. These findings suggest a need for HIV-negative individuals whose HIVST results change to false positive while under storage or under other sub-optimal conditions to be provided with an option for repeat testing to determine their true HIV status.

Indexed as

AdolescentAdultCross-Sectional StudiesFalse Positive ReactionsFemaleHIV InfectionsHumansMaleMass ScreeningPregnancyReagent Kits, DiagnosticSexual PartnersUgandaYoung AdultReagent Kits, DiagnosticConfirmatory HIV testingHIV self-testingUgandaWeak band

Identifiers

PMID31514745
PMCPMC6739989
OpenAlexW2973104114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.